Comparison of total oral bioavailability and the lymphatic transport of halofantrine from three different unsaturated triglycerides in lymph-cannulated conscious rats

被引:46
作者
Holm, R
Müllertz, A
Christensen, E
Hoy, CE
Kristensen, HG
机构
[1] Royal Danish Sch Pharm, Dept Pharmaceut, DK-2100 Copenhagen, Denmark
[2] Tech Univ Denmark, Dept Biochem & Nutr, DK-2800 Lyngby, Denmark
关键词
lymphatic transport; lipid; halofantrine; unsaturated triglycerides; triolein; trilinolein; trilinolenin;
D O I
10.1016/S0928-0987(01)00186-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The lymphatic transport and the portal absorption of the lipophilic drug halofantrine were investigated in a conscious rat model. The rats were dosed with 0.1 g with triolein, trilinolein or trilinolenin containing 2 mg halofantrine. Following oral administration of the triglycerides, the mesenteric lymph and plasma samples were collected. The lymphatic transport for halofantrine was 11.1 +/-1.2 after administration of trilinolein, 9.0 +/-3.5 for trilinolenin and 8.6 +/-2.2 for triolein and the total amount of halofantrine transported in the lymph was linear proportional with the amount of triglyceride in the lymph. The absorption of halofantrine directly into the blood showed a trend towards a higher AUC for trilinolien and trilinolenin compared to triolein, but no statistical difference could be found. The statistically analysis of the mean total bioavailability therefore shows that the absorption of halofantrine was largely independent on triglyceride unsaturation. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 33 条
[1]   HALOFANTRINE - A REVIEW OF ITS ANTIMALARIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL [J].
BRYSON, HM ;
GOA, KL .
DRUGS, 1992, 43 (02) :236-258
[2]  
Caliph SM, 2000, J PHARM SCI, V89, P1073, DOI 10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO
[3]  
2-V
[4]   GASTRIC AND PANCREATIC LIPASE LEVELS DURING A TEST MEAL IN DOGS [J].
CARRIERE, F ;
LAUGIER, R ;
BARROWMAN, JA ;
DOUCHET, I ;
PRIYMENKO, N ;
VERGER, R .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (05) :443-454
[5]   ESTIMATING THE MAXIMAL POTENTIAL FOR INTESTINAL LYMPHATIC TRANSPORT OF LIPOPHILIC DRUG MOLECULES [J].
CHARMAN, WNA ;
STELLA, VJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 34 (1-2) :175-178
[6]   TESTING POTENTIAL DOSAGE FORM STRATEGIES FOR INTESTINAL LYMPHATIC DRUG TRANSPORT - STUDIES IN THE RAT [J].
CHARMAN, WNA ;
NOGUCHI, T ;
STELLA, VJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :173-179
[7]   EFFECTS OF LIPID CLASS AND LIPID VEHICLE VOLUME ON THE INTESTINAL LYMPHATIC TRANSPORT OF DDT [J].
CHARMAN, WNA ;
STELLA, VJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :165-172
[8]   AN EXPERIMENTAL SYSTEM DESIGNED TO STUDY THE INSITU INTESTINAL LYMPHATIC TRANSPORT OF LIPOPHILIC DRUGS IN ANESTHETIZED RATS [J].
CHARMAN, WNA ;
NOGUCHI, T ;
STELLA, VJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 33 (1-3) :155-164
[9]   SOLUBILIZATION AND STABILIZATION OF AN INVESTIGATIONAL ANTI-NEOPLASTIC DRUG (NSC NO-278214) IN AN INTRAVENOUS FORMULATION USING AN EMULSION VEHICLE [J].
ELSAYED, AAA ;
REPTA, AJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 13 (03) :303-312
[10]   INTESTINAL LYMPH LIPOPROTEINS IN RATS FED DIETS ENRICHED IN SPECIFIC FATTY-ACIDS [J].
FELDMAN, EB ;
RUSSELL, BS ;
HAWKINS, CB ;
FORTE, T .
JOURNAL OF NUTRITION, 1983, 113 (11) :2323-2334